NCT07367802 (iKA) is a NA clinical trial of iKA in TKA Outcomes, sponsored by KU Leuven.

Who is sponsoring NCT07367802?

NCT07367802 is sponsored by KU Leuven.

What drugs are being tested in NCT07367802?

Interventions in NCT07367802: iKA.

What condition does NCT07367802 study?

NCT07367802 studies TKA Outcomes.

Is NCT07367802 still recruiting?

NCT07367802 is currently active, enrolled. Last updated 26 January 2026.

Last reviewed 2026-01-26 · How we verify

NCT07367802: iKA

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Exploring the Benefits of a 3D Patient-specific Alignment in Total Knee Arthroplasty

Active, enrolled NA Last updated 26 January 2026

What this trial tests

NA trial testing iKA in TKA Outcomes in 45 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline

1 February 2024

Primary endpoint
1 September 2027

1 September 2027

Quick facts

Lead sponsor	KU Leuven
Phase	NA
Status	Active, enrolled
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	other
Enrollment	45
Start date	1 February 2024
Primary completion	1 September 2027
Estimated completion	1 September 2027
Sites	1 location across Belgium

Drugs / interventions tested

Conditions studied

TKA Outcomes — all drugs for TKA Outcomes →

Sponsor

KU Leuven — full company profile →

Who can join

Adults 55 to 85, any sex, with TKA Outcomes. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

General Aim: to explore the iKA in TKA related to clinical, biomechanical, and functional outcomes.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for TKA Outcomes

Currently open trials in the same condition.

NCT06969222 — l Investigation of Robotic-assisted TKA (RA-TKA) With Skywalker and Evolution Medial Pivot Knee (eMP Knee) · NA · recruiting

Other KU Leuven trials

Trials by the same sponsor.

NCT07508696 — Cerebellar Research in Ultrasound Stimulation · NA · not yet recruiting
NCT07476716 — Peer-modeled Intervention · NA · not yet recruiting
NCT07534384 — Automated CPET Interpretation: International Validation Study · not yet recruiting
NCT07419555 — Belgian Lung Function Study · recruiting
NCT07295600 — Postprandial Effect of Isocaloric Challenge Meals Enriched With Indigenous Fruits and Vegetables on Glucose Metabolism i · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07367802 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by KU Leuven
Last refreshed: 26 January 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07367802.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing